Novartis preview - Q1 sales seen strong ahead of U.S. patent expiries, Pluvicto expansion in focus By Investing.com
- Posted on April 30, 2025
- By Investing.com
- 3 Views
Novartis preview - Q1 sales seen strong ahead of U.S. patent expiries, Pluvicto expansion in focus By Investing.com
Novartis preview - Q1 sales seen strong ahead of U.S. patent expiries, Pluvicto expansion in focus
